Pharmacovigilance
Chiesi Farmaceutici has a system of pharmacovigilance in order to assume liability for our medicinal products (whether marketed or under clinical development) and to take appropriate actions when necessary. We ensure that all information relevant to the benefit-risk ratio of our medicinal products is continuously evaluated. When important safety issues arise, if applicable, we promptly notify healthcare professionals, patients and regulatory agencies concerned in accordance with current legislation.
What is pharmacovigilance?
Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem (Ref. World Health Organization, WHO. The importance of pharmacovigilance: safety monitoring of medicinal products, Genève, WHO, 2002).
In line with this general definition, the main objectives of pharmacovigilance in accordance with the applicable EU legislation are: preventing harm from adverse reactions in humans; promoting the safe and effective use of medicinal products, in particular by providing timely information about the safety of medicinal products for patients, healthcare professionals and the public.
Pharmacovigilance is therefore an activity contributing to the protection of patient and public health.
What is an adverse drug reaction?
A response to a medicinal product which is harmful and unintended (response in this context means that a causal relationship between a medicinal product and an adverse event is at least a reasonable possibility). Adverse reactions may arise from use of the product within or outside the terms of the marketing authorization or from occupational exposure. Conditions of use outside the marketing authorization include off-label use, overdose, misuse, abuse and medication errors.
What is the materiovigilance?
The Medical Device Vigilance (materiovigilance) is a system aimed at monitoring and evaluating incidents related to medical devices. The Medical Device Vigilance System aims to improve the protection of the health and safety of patients, healthcare professionals, and other users by reducing the likelihood of reoccurrence of incidents related to the use of a medical device.
What is an incident or an untoward event related to a medical device?
The term “incident” in the Medical Device Regulation (UE) 2017/745 means any malfunction or deterioration in the characteristics or performance of a device made available on the market, including use-error due to ergonomic features, as well as any inadequacy in the information supplied by the manufacturer and any undesirable side-effect.
Information on how to report an adverse drug reaction or a medical device incident
Each country has its own national laws governing the reporting of adverse drug reactions or medical device incidents. Patients and healthcare professionals should refer to national regulations for reporting.
You have the possibility to report directly to the Marketing Authorization Holder (MAH) of the drug that you suspect has caused the adverse reaction or to the Manufacturer of the medical device that may have caused the incident.
If you wish to notify directly to Chiesi, please enter the country where the event occurred in the appropriate field and use the contact details provided.
Country where the event/accident took place:
Afghanistan
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Albania
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Algeria
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Andorra
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Angola
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Antigua and Barbuda
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Argentina
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Armenia
Email: pharmacovigilance.ru@chiesi.com
Tel: +7 495 967 12 12
+7 903 008 00 74
+7 964 518 02 56
Fax: +7 495 967 12 11
Australia
Email: pv.au@chiesi.com
For medicinal drugs Birch bark extract, Lomitapide, Metreleptine and Octreotide acetate: cds@chiesi.com
Austria
Email: medinfo.at@chiesi.com
Tel: +43 1 407 39 19 - 0
Fax: +43 1 407 39 19 - 99018
Note: outside normal business hours: +43 676 88 555 518
Azerbaijan
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Bahamas
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Bahrain
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Bangladesh
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Barbados
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Belarus
Email: pharmacovigilance.ru@chiesi.com
Tel: +7 495 967 12 12
+7 903 008 00 74
+7 964 518 02 56
Fax: +7 495 967 12 11
Belgium
Email: pv.benelux@chiesi.com
Tel: +32 (0)2 788 42 00
Belize
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Benin
Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08
Bhutan
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Bolivia
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Bosnia and Herzegovina
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Botswana
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Brazil
Email: farmacovigilancia.br@chiesi.com
Brunei
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Bulgaria
Email: office.bg@chiesi.com
Tel: +359 2 920 12 05
Note: Tel. (availability 24h): +359 885 150 578
For medicinal drugs Birch bark extract, Deferiprone, Idebenone, Lomitapide, Mercaptamine bitartrate, Metreleptine, Pegunigalsidase alfa e Velmanase alfa: cds@chiesi.com
Burkina Faso
Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08
Burundi
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Cambodia
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Cameroon
Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08
Canada
Email: cds@chiesi.com
Note: For medicinal drug Ferriprox: ca.pharmacovigilance@chiesi.com 1-800-854-3534
Cape Verde
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Central African Republic
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Chad
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Chile
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
China
Email: drugsafety.cn@chiesi.com
Tel: +86 18616354367
Colombia
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Comoros
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Cook Islands
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Costa Rica
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Croatia
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Cuba
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Cyprus
Email: pharmacovigilance.gr@chiesi.com
Tel: :+30 210 6179763
Fax: +30 210 6179787
For medicinal drugs Birch bark extract, Deferiprone, Lomitapide, Metreleptine: cds@chiesi.com
Czech Republic
Email: safety.cz@chiesi.com
Tel: +420 261 211 850
Fax: +420 261 221 767
For medicinal drugs Birch bark extract, Lomitapide, Metreleptine: cds@chiesi.com
Democratic Republic of Congo
Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08
Denmark
Email: pharmacovigilancenordic@chiesi.com
Tel: +46 8 753 35 20
Djibouti
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Dominica
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Dominican Republic
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
East Timor
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Ecuador
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Egypt
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
El Salvador
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Equatorial Guinea
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Eritrea
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Estonia
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Eswatini
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Ethiopia
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Federated States of Micronesia
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Fiji
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Finland
Email: pharmacovigilancenordic@chiesi.com
Tel: +46 8 753 35 20
France
Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08
Gabon
Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08
Gambia
Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08
Georgia
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Germany
Email: DE-AMS@chiesi.com
Fax: +49 (0)40 897 24-270
Ghana
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Greece
Email: pharmacovigilance.gr@chiesi.com
Tel:+30 210 6179763
Fax: +30 210 6179786
For medicinal drugs Birch bark extract, Deferiprone, Lomitapide, Metreleptine: cds@chiesi.com
Grenada
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Guatemala
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Guinea
Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08
Guinea-Bissau
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Guyana
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Haiti
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Honduras
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Hong Kong
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Hungary
Email: mellekhatas@chiesi.com
Tel: +36 1 429 1060
Fax: +36 1 429 1064
For medicinal drugs Birch bark extract, Deferiprone, Idebenone, Lomitapide, Mercaptamine bitartrate, Metreleptine, Pegunigalsidase alfa and Velmanase alfa: cds@chiesi.com
Iceland
Email: pharmacovigilancenordic@chiesi.com
Tel: +46 8 753 35 20
India
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Indonesia
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Iran
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Iraq
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Israel
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Italy
Email: farmacovigilanza@chiesi.com
Tel: +39 0521 2791
Ivory Coast
Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08
Jamaica
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Japan
Email: pv.japan@chiesi.com
Tel: +81 120 484648
Jordan
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Kazakhstan
Email: pharmacovigilance.ru@chiesi.com
Tel: +7 495 967 12 12
+7 903 008 00 74
+7 964 518 02 56
Fax: +7 495 967 12 11
Kenya
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Kiribati
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Kosovo
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Kuwait
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Kyrgyzstan
Email: pharmacovigilance.ru@chiesi.com
Tel: +7 495 967 12 12
+7 903 008 00 74
+7 964 518 02 56
Fax: +7 495 967 12 11
Laos
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Latvia
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Lebanon
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Lesotho
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Liberia
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Libya
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Liechtenstein
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Lithuania
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Luxembourg
Email: pv.benelux@chiesi.com
Tel: +32 (0)2 788 42 00
Madagascar
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Malawi
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Malaysia
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Maldives
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Mali
Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08
Malta
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Marshall Islands
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Mauritania
Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08
Mauritius
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Mexico
Email: farmacovigilancia.mx@chiesi.com
Tel: 800 200 02 60
Mobile: +56 199 99 227
For medicinal drugs Birch bark extract, Lomitapide, Metreleptine and Octreotide acetate: cds@chiesi.com
Moldova
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Monaco
Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax: +33 1 47 68 48 08
Mongolia
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Montenegro
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Morocco
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Mozambique
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Myanmar
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Namibia
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Nauru
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Nepal
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Netherlands
Email: pv.benelux@chiesi.com
Tel: +31 (0)88 501 64 00
New Zealand
Email: pv.au@chiesi.com
Nicaragua
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Niger
Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08
Nigeria
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
North Korea
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
North Macedonia
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Norway
Email: pharmacovigilancenordic@chiesi.com
Tel: +46 8 753 35 20
Oman
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Pakistan
Email: Pv.pk@chiesi.com
Tel: +92-3458407000
Fax: +92-42-111244374
For medicinal drugs Birch bark extract, Lomitapide, Metreleptine and Octreotide acetate: cds@chiesi.com
Palau
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Palestinian Authority
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Panama
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Papua New Guinea
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Paraguay
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Peru
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Philippines
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Poland
Email: apvpl@chiesi.com
Tel: +48 22 620 14 21
Fax: +48 22 652 37 79
For medicinal drugs Birch bark extract, Deferiprone, Idebenone, Lomitapide, Mercaptamine bitartrate, Metreleptine, Pegunigalsidase alfa and Velmanase alfa: cds@chiesi.com
Portugal
Email: safety@pharmaffairs.com
Tel: +351 21 124 6807
Qatar
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Republic of Ireland
Email: pv.uk@chiesi.com
Tel: 1800 817459
Note: The freephone number for Ireland will only work if phoning from within Ireland. It does not work from abroad.
Romania
Email: medinfo.ro@chiesi.com
Tel: +40212023642
Fax: +40212023643
For medicinal drugs Birch bark extract, Lomitapide, Metreleptine: cds@chiesi.com
Russia
Email: pharmacovigilance.ru@chiesi.com
Tel: +7 495 967 12 12
+7 903 008 00 74
+7 964 518 02 56
Fax: +7 495 967 12 11
Rwanda
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Saint Kitts and Nevis
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Saint Lucia
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Saint Vincent and the Grenadines
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Samoa
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
San Marino
Email: farmacovigilanza@chiesi.com
Tel: +39 0521 2791
Saudi Arabia
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Senegal
Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08
Serbia
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Seychelles
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Sierra Leone
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Singapore
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Slovakia
Email: pharmacovigilance.sk@chiesi.com
For medicinal drugs Birch bark extract, Lomitapide, Metreleptine: cds@chiesi.com
Slovenia
Email: farmakovigilanca.si@chiesi.com
For medicinal drugs Birch bark extract, Lomitapide, Metreleptine: cds@chiesi.com
Solomon Islands
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Somalia
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
South Africa
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
South Korea
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
South Sudan
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Spain
Email: farmacovigilancia@chiesi.com
Tel: +34 93 494 80 00
Sri Lanka
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Sudan
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Suriname
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Sweden
Email: pharmacovigilancenordic@chiesi.com
Tel: +46 8 753 35 20
Switzerland
Email: chiesisa_pv@ompharma.com
Tel: +41 22 783 14 44
Fax: +41 22 783 16 01
For medicinal drugs Lomitapide, Metreleptine: cds@chiesi.com
Syria
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
São Tomé and Príncipe
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Taiwan
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Tajikistan
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Tanzania
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Thailand
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
The Gambia
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Togo
Email: pharmacovigilance@chiesi.com
Tel: +33 1 47 68 88 99
Fax : +33 1 47 68 48 08
Tonga
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Trinidad and Tobago
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Tunisia
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Turkey
Email: info.tr@chiesi.com
Tel: +90 212 370 91 00
Fax: +90 212 370 91 27
For medicinal drugs Birch bark extract, Lomitapide, Metreleptine, Octreotide acetate and Velmanase alfa: cds@chiesi.com
Turkmenistan
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Tuvalu
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Uganda
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Ukraine
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
United Arab Emirates
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
United Kingdom
Email: pv.uk@chiesi.com
Tel: +44 (0)800 0092329
United States
Email: us.medical@chiesi.com
Tel: 1-888-661-9260
Fax: 1-866-443-3092
Uruguay
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Uzbekistan
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Vanuatu
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Vatican City
Email: farmacovigilanza@chiesi.com
Tel: +39 0521 2791
Venezuela
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Vietnam
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Yemen
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Zambia
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com
Zimbabwe
Adverse Drug Reaction with medicinal product:
cds@chiesi.com
Incident with Medical Device:
MDchiesi@chiesi.com